key: cord-1025251-jodqwx98
authors: Mateus, Daniela; Sebastião, Ana Isabel; Carrascal, Mylène A.; do Carmo, Anália; Matos, Ana Miguel; Cruz, Maria Teresa
title: Crosstalk between estrogen, dendritic cells, and SARS‐CoV‐2 infection
date: 2021-09-17
journal: Rev Med Virol
DOI: 10.1002/rmv.2290
sha: ed3fc7b9efe2e0f3f16f4373ba728a3c2532d4ba
doc_id: 1025251
cord_uid: jodqwx98

The novel coronavirus disease 2019 (Covid‐19) first appeared in Wuhan and has so far killed more than four million people worldwide. Men are more affected than women by Covid‐19, but the cellular and molecular mechanisms behind these differences are largely unknown. One plausible explanation is that differences in sex hormones could partially account for this distinct prevalence in both sexes. Accordingly, several papers have reported a protective role of 17β‐estradiol during Covid‐19, which might help explain why women appear less likely to die from Covid‐19 than men. 17β‐estradiol is the predominant and most biologically active endogenous estrogen, which signals through estrogen receptor α, estrogen receptor β, and G protein‐coupled estrogen receptor 1. These receptors are expressed in mature cells from the innate and the adaptive immune system, particularly on dendritic cells (DCs), suggesting that estrogens could modulate their effector functions. DCs are the most specialized and proficient antigen‐presenting cells, acting at the interface of innate and adaptive immunity with a powerful capacity to prime antigen‐specific naive CD8+ T cells. DCs are richly abundant in the lung where they respond to viral infection. A relative increase of mature DCs in broncho‐alveolar lavage fluids from Covid‐19 patients has already been reported. Here we will describe how SARS‐CoV‐2 acts on DCs, the role of estrogen on DC immunobiology, summarise the impact of sex hormones on the immune response against Covid‐19, and explore clinical trials regarding Covid‐19

The novel coronavirus disease 2019 (Covid- 19) was first recognized in late 2019 in Wuhan, China as caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has become the biggest pandemic of this century. 1 The morbidity and mortality of have not decreased despite our efforts to prevent and treat the disease, accumulating more than 186 million people infected and more than four million deaths until now. 2 Epidemiological data shows a higher mortality rate in men over women. 3 Several reports clearly demonstrate that female patients have a better prognosis than males, most probably due to differences in the levels of sex hormones, namely in 17β-estradiol. 4 Indeed, the hormonal fluctuations during physiological changes in premenopausal women warrant their stronger immune protection. 5 Estrogen exerts its effects through the estrogen receptors (ERs) ERα, Erβ, and G-protein-coupled estrogen receptor (GPER) 1, which are widely expressed in most tissues, including in mature cells from the innate immune system, such as dendritic cells (DCs), and the adaptive immune system, [6] [7] [8] suggesting that estrogens could have a relevant role in the response mediated by the immune system against several pathogenic agents, including SARS-CoV-2. 9 DCs play a key role in generating a robust immune response, as they are the most powerful antigen-presenting cells (APCs) with the ability to stimulate the activation of T and B lymphocytes, providing a crucial link between innate and adaptative immunity. Typically, DCs are found in an immature state at areas of the body that are close to the outside environment, which includes skin, and mucosa of respiratory and gastrointestinal tracts. Upon exposure to an infectious agent, DCs capture and process it, displaying the resulting antigens on major histocompatibility complex (MHC)-I or MHC-II molecules. Simultaneously, DCs start to mature and migrate towards the draining lymph nodes where they present the processed antigens to naïve T cells, initiating a specific immune response. 10 Nevertheless, if the innate and adaptive immune responses are dysregulated and pro-inflammatory cytokine production becomes uncontrolled, this cytokine storm 11 This review surveys the state of the knowledge regarding estrogen-dependent regulation of DCs biology and its impact upon SARS-CoV-2 progression. Finally, we will display some clinical trials whose purpose is to understand whether the drugs or drug associations which interference with the signaling pathways triggered by sex hormones are beneficial for Covid-19 patients.

Covid-19, which can drive in highly infectious pneumonia, was first reported in Wuhan, Hubei Province, China, in December 2019 12 and was latter recognized as a pandemic by the World Health Organization. Covid-19 is triggered by SARS-CoV-2, a designation assigned by the Coronavirus study group of the International Committee on Taxonomy of Viruses. 13 Coronaviruses (CoVs) belong to the Coronaviridae family and Orthocoronavirinae subfamily. This subfamily is genotypically and serologically divided into four genera, the α, β, ɣ, and δ coronaviruses.

SARS-CoV-2 is a β-coronavirus, enveloped, with a nonsegmented positive-sense single-stranded ribonucleic acid (RNA) genome. CoV genome is the largest among all the RNA viruses and codes for at least four major proteins: spike (S), envelope (E), membrane (M), nucleocapsid (N), and other accessory proteins that help the replicative process and facilitate entry into host cells (Figure 1a ). 14 CoVs originally transmitted from animals to humans are transferred from one individual to another through the kind of aerosolization caused by coughing or sneezing to reach the respiratory tract. 15 Bats and rodents represent the common reservoir hosts for α and β-CoVs, compared to birds for the ɣ and δ genera. However, this type of virus is able to jump from its physiological reservoirs to other animals, representing an example of virus evolution with high genetic variability and great potential for recombination. These features are expected to change the biological characteristics of the virus and are important factors predisposing to novel pandemics. 16 Crucial steps of the invasion of the host cell by SARS-CoV-2 are the identification of target cells, S protein cleavage, and entry into the host cell. In brief, S protein contains two major functional domains, the N-terminal region (named S1) and a C-terminal region (named S2). S1

includes a receptor-binding domain (RBD) that recognizes and binds to its target cell surface receptor, namely, angiotensin-converting enzyme 2 (ACE2). S2 is crucial to the fusion between the virus envelope and the membrane of the target cell, allowing virus genetic material entry. After binding to ACE2, an initial cleavage of S protein at the S1/S2 site is required. This S2 0 cleavage site can be recognized and cut by the host transmembrane serine protease 2 (TMPRSS2), as well as by prohormone convertase 1 (PC1), trypsin-like proteases and cathepsins. 17 The proteolysis produces a mature S2 fusion protein, which allows virus entry into host cells. 18 This pre-activation of the S protein can also be made by furin, which is ubiquitously expressed (except in muscle cells, where furin is expressed in a low level) and localized at the cell surface and in intracellular compartments, being able to process both cytosolic and extracellular substrates. 19 The abundant intracellular furin suggests that infected cells might release pre-activated viruses, that can be fused without an ACE2 interaction, increasing virus transmissibility. 18 Type II alveolar cells express ACE2, allowing the infection by SARS-CoV-2. After entry into the host cell, viral positive-sense RNA links to cellular ribosomes and uses cell machinery to produce new viral proteins and genomes, and, ultimately, progeny virions. 20 Subsequently, the host cell releases inflammatory mediators that activate alveolar macrophages to release cytokines, such as interleukin (IL)-1, IL-6, and tumor necrosis factor-α (TNF-α).

The excess cytokines reach the hypothalamus and direct it to increase the body temperature (fever). 21 Additionally, this cytokine burst destroys the endothelial layer inside the capillary around the alveolus, promoting vessel dilation and capillary permeability. As a result, the alveolar edema reduces the production of surfactants, leading to alveolar collapse and impaired gas exchange mechanism. Consequently, the contraction of bronchial smooth muscle induces or enhances cough sensitivity. On the other hand, the inflammatory mediators, such as prostaglandin and bradykinin, also promote the cough reflex by sensitizing cough receptors. 22 If the lung inflammation is severe, it can stimulate a systemic inflammatory response, increasing vessel permeability. As a result, the plasma fluid leaks into tissue space, decreasing blood volume, which may eventually reduce the perfusion of the organs and lead to multiple organ failure. 23

DCs play a key role in generating a robust immune response, as they are the most powerful APCs with strong migration ability. Mature DCs can stimulate the activation of T and B lymphocytes, providing a F I G U R E 1 (a) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) structure. SARS-CoV-2 is a virus enveloped with a nonsegmented positive-sense single-stranded ribonucleic acid ((+)ss-RNA) genome. Their genome codes for four major proteins: spike protein, envelope protein, membrane protein, nucleocapsid, and accessory proteins. 11 (b) . How SARS-CoV-2 acts on dendritic cells. When SARS-CoV-2 infects the respiratory tract, the host innate immune system detects viral infection by using pattern recognition receptors, including toll-like receptor (TLR), to recognize damage-associated molecular patterns and pathogen-associated molecular patterns, like-proteins, lipoproteins, and nucleic acids of viral origin. 30 The plasmacytoid dendritic cells (pDCs) could recognize ss-RNA viruses via TLR7. 31 Subsequently the interferon regulatory factor (IRF)-7 is activated to induce the production of pro-inflammatory cytokines, such as interferon (INF)-α. 32 (c). Estrogen receptors (ERs). Following interaction with its ligand (E), the ER can modulate cellular function through nuclear genomic (1,2,3) or non-genomic (4) mechanisms. (1) Nuclear E-ER binds directly to estrogen receptor element in target gene promoters. (2) Nuclear E-ER is tethered through protein-protein interactions to a transcription factor complex (TF) that contacts the target gene promoter. (3) Growth factors activate protein-kinase cascades, leading to phosphorylation (P) and activation of nuclear ER at the target gene. (4) Membrane E-ER complexes activate protein-kinase cascades, leading to altered functions of proteins in the cytoplasm (e.g., activation of eNOS) or the regulation of gene expression through phosphorylation (P) and activation of a TF. 55 (d) . How estrogen acts on dendritic cells. The culture of bone marrow cells in the presence of granulocyte-macrophage colony-stimulating factor, has shown the crucial role of estrogen (E) in the culture medium in promoting the development of CD103 + cDCs and CD11b + cDCs. 59 The CD11b + cDC subset displayed higher levels of cell surface CD86, exhibiting superior ability to induce the proliferation of naive CD4 + T cells. 62 However, estrogen decreases the absolute number of pDCs, led to a more mature phenotype development and an enhanced capacity to produce interleukin (IL)-12 in response to TLR9 stimulation. 65 Subsequently, the high levels of IL-12 induce the differentiation of Th1 cells. 66 The higher levels of estrogen also enhance the TLR7-dependent production of IFN-α by pDCs, increasing the immune response against the virus. 63,64 (e). The effect of 17β-estradiol levels on angiotensinconverting enzyme (ACE)2 and transmembrane serine protease (TMPRSS)2 expression. Pre-treatment of the VERO E6 cell line with 17βestradiol showed that estrogen significantly downregulated TMPRSS2 messenger RNA (mRNA) expression. 6 Similarly, normal human bronchial epithelial cells pre-treated with 17β-estradiol expressed lower levels of ACE2 mRNA. 73 In spite of the downregulation of TMPRSS2 mRNA and ACE2 mRNA, it might not translate into a reduction of protein expression at the cell surface (red arrow). Created with BioRender.com MATEUS ET AL.

-3 of 15 crucial link between innate and adaptative immunity. They are able to recognize, capture, process, present antigens, and produce cytokines in the presence of pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs). 24 pDCs are able to produce type I interferons (IFN) upon viral infection, however, in their immature state, they may be involved in immune suppression. cDCs can be also subdivided according to their location: (i) lymphoid organ-resident DCs, (ii) peripheral tissueresident DCs, and (iii) circulating DCs. Immature DCs are located at body surfaces with potential antigen entry, such as the skin and mucosal at the respiratory, genitourinary, and gastrointestinal systems. 10 During maturation, DCs migrate to lymphoid tissues where they can activate naive B and T lymphocytes, the latter through antigen presentation by peptide-MHC complexes on the surface of DCs. DCs may also interact with cells of the innate immune system, such as macrophages, natural killer cells, and mast cells, thus modulating the global immune response. 24 When the maturation process of DCs is blocked, it directly affects the initiation of the adaptative immune response and, consequently, pathogen clearance.

DCs, along with the alveolar macrophages, constitute the first line of sentinel cells in the innate immune response against respiratory viral infection. In steady state, lung DCs of mice can be subdivided into CD11c hi CD103 + cDCs (human cDC1 subset) that belong to the CD8a type cDCs, CD11c hi CD11b + cDCs (human cDC2 subset), and CD11c dim pDCs (human pDCs subset). During inflammation, moDCs are recruited to the lung and some of CD11c hi CD11b + cDCs can acquire a CD103 + CD11b + phenotype. CD103 + CD11b + cDCs migrate from the intraepithelial base to the draining mediastinal lymph nodes to primarily induce the CD8 + T cell immune response against respiratory viruses. 25

Due to the recentness of the SARS-CoV-2, many reports have turned to accumulated evidence on previous coronaviruses. Taking this into account, the data herein described crosses the information available from the SARS-CoV and Middle East Respiratory syndrome coronavirus (MERS-CoV) to fill the knowledge gap on the new SARS-CoV-2. 26 When SARS-CoV-2 reaches the respiratory tract, as stated previously, it enters into cells expressing ACE2. 17 As DCs in intraalveolar septa of the lung express ACE2, it is plausible to speculate that these immune sentinels can be infected by SARS-CoV-2. 27 In addition to the recognition receptors, DCs also express attachment receptors, such as dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN), which augments infection by SARS-CoV of already permissive cells, that is cells that express ACE2. 28 In fact, Chan et al. reported that patients with reduced DC-SIGN expression had a lower risk of having severe SARS-CoV infection. 29 The host innate immune system detects viral infection by using PRRs, including TLR, to recognize PAMPs likeproteins, lipoproteins, and nucleic acids of viral origin. 30 observed that immature moDCs were permissive for MERS-CoV, whereas mature moDCs were not, without upregulation of proinflammatory cytokines and chemokines. 36 Taking into account that the maturation state of DCs is required to activate T cells, 37 41 Yang et al. 43 reported that moDCs and monocyte-derived macrophages (MDMs) support SARS-CoV-2 protein production but did not efficiently support virus replication and generation of infectious virus progenies. 43 A recent study evaluated the proportion and functionality of cDC and pDC subsets derived from acute and convalescent Covid-19 patients and healthy donors. 46 The convalescent patients showed an increased frequency of CD11c + cDCs in total DCs. Furthermore, the cDC:pDC ratio in acute patients was higher (especially in severe cases) in comparison with those in the healthy donors and convalescent patients, suggesting a link between the reduction in pDCs and poor outcomes. 46 Both acute and convalescent patients presented a significant decrease in expression of the co-stimulatory molecule CD86, which is also related to cDCs maturation. 46 These findings suggest that SARS-CoV-2 negatively impacts DCs numbers and functions, which may explain the worst Covid-19 outcomes. 43 Therefore, the knowledge of the mechanisms through which SARS-CoV-2 mitigates DCs function is of paramount importance to identify new molecular targets for disease treatment. Accordingly, the Aivita Biomedical Company, focused on the design of personalized vaccines, and has recently started an adaptive Phase I-II trial (NCT04386252) of a vaccine consisting of autologous DCs loaded ex vivo with SARS-CoV-2 S protein, with or without GM-CSF, to prevent Covid-19 in adults. Nevertheless, there is no more information about the results of this trial. 47

As previously mentioned, there are two classical nuclear ERs: ERα and ERβ, and one transmembrane ER, GPER1, which are encoded by ESR1 on chromosome 6, ESR2 on chromosome 14, and GPER on chromosome 7, respectively. 6, 48 ERα is mainly expressed in immune cells, reproductive tissues, breast, bone, kidney, liver, and white adipose tissue, while ERβ is found in the immune cells, lung, central nervous system, cardiovascular system, ovary, prostate, male reproductive organs, colon, and kidney. 48 GPER1 is also expressed in the immune, central nervous, reproductive, renal and cardiovascular systems. 49 ERs may also follow a tethered signaling pathway, interacting with other transcription factor complexes and binding to non-ERE sequences (Figure 1c ). 50 The transcription factor complexes include activator protein 1 (AP-1), STATs, activation transcription factor 2 (ATF-2), NF-κB, specificity protein 1 (SP1), which are bound to their cognate DNA binding sites. 55 The genes regulated by ERα are distinct from those regulated by ERβ in response to estrogens, which act as agonists in all tissues, even though they can produce opposite effects. Tee et al. reported that only 38 of the 228 (17%) genes are regulated by both ERα and ERβ with E2. Furthermore, they verified that the regulation of some gene expression by E2 was dose dependent. 56 The recruitment of different coregulatory proteins (such as co-activators, chromatin modulators, and basal transcription factors) to EREs also impacts gene transcription. 50, 56 Different types of EREs in target promoters, the differential utilization of coregulators, and the relative expression of ERα and ERβ in different cell types justify the complexity of ER-mediated gene transcription. 56 GPER1 is a 7-transmembrane G protein-coupled receptor which mediates both rapid genomic and nongenomic transcriptional responses estrogen-dependent, such as activation of adenylyl cyclase and transactivation of epidermal growth factor receptor. 49, 57 Interestingly, this receptor showed to have an impact on the expression of IL-6, once their blockage leads to IL-6 expression decrease. 8 MATEUS ET AL. demonstrated that CD11b + DC from E2-supplemented medium displayed higher levels of cell surface CD86, exhibiting superior ability to induce the proliferation of naive CD4 + T cells. 62 The high levels of estradiol also influence T regulatory (Treg) cell populations. 63 The presence of Flt3L in the culture medium generates cDCs and pDCs subsets from bone marrow progenitors. However, E2

downregulates the development of these Flt3L-driven CD11c + DCs through ERα-signaling in progenitors, compromising the absolute number of pDCs, whereas cDCs were slightly changed. 9, 64 The decreased pDCs absolute number led to a more mature phenotype development and an enhanced capacity to produce IL-12 in response to TLR9 stimulation. 65 Subsequently, the high levels of IL-12 induce the production of IFNγ and the differentiation of Th1 cells, leading to a greater antiviral immune response. 66 Of relevance, estrogen also regulates the TLR7-mediated antiviral response of pDCs 65 TLR7 is a receptor expressed on DCs that responds to singlestranded viral RNA. 75 Berghöfer et al. 76 demonstrated that pDCs in the peripheral blood of women produced more type I IFNs in response to TLR7 ligands than pDCs from men. 76 The authors observed that pDCs from postmenopausal women exhibited a reduced TLR7-mediated response by comparison with premenopausal women, which was partially preserved by hormone replacement therapy with E2, 76 suggesting that estrogens have a key role in regulating TLR-mediated response. 67, 68 Progesterone can also modulate immune responses by binding to progesterone receptors located in immune cells, including natural killer cells, T lymphocytes, macrophages, and DCs, as well in Androgens, such as dihydrotestosterone and testosterone, may also have a protective role in younger men. This effect results from the interaction with the androgen receptor (AR). 80 It was reported that testosterone modulates the immune response, downregulating the expression and function of inflammatory cytokines, including, IL-6, IL-1β, and TNF-α. 81 Furthermore, testosterone enhances Treg and suppresses Th17 differentiation, thus attenuating pro-inflammatory immune response. 82 Testosterone also reduces both neutrophil and eosinophil recruitment, impairing Th2 activation, B cell proliferation and consequently humoral response. 83, 84 It is important to highlight that aromatase uses the androgenic substrates to convert them into their respective estrogen, which might trigger an anti-inflammatory effect. 85 Nonetheless, low levels of testosterone, typically verified with aging, may revert these immunological features predisposing patients to systemic inflammation and worse clinical outcomes. On the other hand, androgens seem to enhance TMPRSS2 gene expression, triggering a greater viral entry of SARS-CoV-2 into target cells. 86 Thereby, aging may impair immune response against SARS-CoV-2 infection, particularly in men. Physiological levels of testosterone lead to a dampened immune response, allowing systemic SARS-CoV-2 spreading with the injurious clinical outcome on one side, but protecting them against cytokine storm on the other side. [81] [82] [83] [84] [85] [86] In addition, progesterone seems to keep the balance between pro and anti-inflammatory immune responses, enhancing the estrogen antiviral response against SARS-CoV-2. 77 Thus, not only estrogen but sex hormones all together might justify the differences between genders ( Figure 2 ) and age rates.

Discrepancies between sex can be justified by other mechanisms, such as the imbalance expression of genes on the Y-and Xchromosomes, since immune-related genes linked to chromosome X appear to be more activated in female immune cells. Females carry polymorphic X-chromosomes from both parents, providing an advantage to be potentially heterozygous, whereas males carry only the maternal X-chromosome, who are definitely hemizygous. 87 During early female embryonic development, one of the X-chromosome is inactivated randomly for gene expression, resulting in cellular F I G U R E 2 Sex differences during novel coronavirus disease 2019 (Covid-19). Sex differences from confirmed cases, intensive care unit admissions, and deaths during Covid-19. There are differences between sexes with male patients showing higher morbidity and mortality than female patients. The data was obtained from Global Health 5050 on 17 th August 2021 3 MATEUS ET AL. mosaicism for the expression of X-related proteins, which may contribute to sex-related dimorphism, favouring females with greater adaptability to counteract the progression of the SARS-CoV-2 infection. 88 The X-chromosome has the ACE2 gene 89 as well as genes related to the immune system, including TLR7, TLR8, IRAK1, NFκB essential modulator (NEMO), among others. 90 To understand the impact of polymorphism in the TLR7, IRAK1, and NEMO genes on Covid-19 we will describe the signaling cascade initiated by TLR7 after the recognition of single-stranded RNA (ssRNA) viruses. TLR7, which is located in the endosomes, recognizes ssRNA trough the MyD88. Then, it is formed a complex with IRAK-1, IRAK-4 and TRFA6. If TRFA6 activates IRF7, this IRF will be translocated to the nucleus to promote the synthesis of the type I IFN. 33 On the other way, TRFA6 could activate the complex formed by NFκB-inhibitory kinases (IKKα and β) and NEMO. The phosphorylation of the NFκBinhibitory proteins by IKKα and IKKβ activates the NFκB and increases the pro-inflammatory response. 33, 91 Fallerini et al. reported that missense deleterious variants in the X-linked recessive TLR7 gene may increase susceptibility to Covid-19 in 2.2% of severely affected young males patients. 92 The polymorphism in the human IRAK1 haplotype seems to persistently increase its kinase activity, which translates into an augmented pro-inflammatory immune response. 33, 93 Taking into account that ACE2 is directly correlated with the SARS-CoV infection, 94 Hussain et al. explored the binding affinity between ACE2 variants and SARS-CoV-2 S protein. The team highlighted only two probable alleles (rs73635825 (S19P) and rs143936283 (E329G)) of ACE2 that may impact the susceptibility and/or resistance against SARS-CoV-2. 95 Nevertheless, human ACE2 gene is localized on Xp22, in an area where genes are reported to escape from X-inactivation. 96 Souyris et al. also demonstrated that TLR7 escapes from X-inactivation in B lymphocytes and myeloid cells. 97 Thereby, the cell mosaicism and the inactivation of the Xchromosome may be the explanation for the immune hyperresponsiveness verified in females. 98 

Women may be more protected than men during physiological changes, including pregnancy or the menstrual cycle when the oscillation of reproductive steroids warrants stronger immune protection. Studies have noted that some SARS-CoV-2 positive pregnant women with mild Covid-19 symptoms or asymptomatic on admission to obstetrical unit, intensified symptom severity immediately postpartum in coincidence with the drastic hormonal decrease following childbirth. 5 In the early stages of pregnancy, peripartum, and postpartum a proinflammatory response is reported, despite the rest of pregnancy revealing an anti-inflammatory response. The proinflammatory state is characterized by Th1 and Th17 cells, resulting in the overproduction of pro-inflammatory mediators, including TNF-α, IL-6, IL-1β. The anti-inflammatory state is Th2 and Treg cells dominated with the overproduction of anti-inflammatory cytokines, such as IL-4, IL-10, and TGF-β. The anti-inflammatory response is amplified by placental hormones (estriol, estradiol, progesterone, human chorionic gonadotropin, prostaglandins), type 2 macrophages, and leukemic inhibitory factor. 99 IL-10 can promote anti-inflammatory and antifibrotic actions in the lungs and other tissues by suppressing the Th-1 immunity. 100 Further, IL-10 also enhances B lymphocytes survival and antibody production, which is crucial to balance the immune suppression and activation. 101 In contrast, proteaseactivated receptors (PAR)-1 and IL-6 are responsible for the deterioration of Covid-19 patients due to the overproduction of proinflammatory cytokines and the activation of the coagulation pathway. 102 This will lead to exacerbated inflammatory response and procoagulant-anticoagulant imbalance, which in turn results in extensive tissue damage, diffused micro thrombosis, and multiorgan failure. In a normal pregnancy, however, PAR-1 is undetectable after the first trimester. 103 Concretely, both estrogens and progesterone seem to display a protective effect, and testosterone seems to lead to a dampened immune response, allowing systemic SARS-CoV-2 spreading. 104 With these principles in mind, it is possible to speculate that interfering with the signaling pathways triggered by sex hormones may control the severity of Covid-19. In fact, some clinical trials are assessing this hypothesis currently. In Figure 3 we present active clinical trials aiming to understand whether the drugs or drug associations are beneficial for Covid-19 patients.

Some of the strategies are the sex hormones previously described, whereas other incorporate molecules that are not even hormones. However, those molecules modulate the cell response due to the presence of sex hormones by different mechanisms. Next, we will deeply discuss their mechanisms.

Degarelix, Enzalutamide, and Bicalutamide are drugs that are currently used to treat prostate cancer. 105, 106 However, their mechanisms of action are slightly different from one another.

Degarelix is a selective, competitive, and reversible antagonist of the gonadotropin-realizing hormone (GnRH) receptors located on hypophysis. As a result, the gonadotropins (which are luteinizing hormone-LH, and follicle-stimulating hormone-FSH) release is decreased, leading consequently to the reduction of testosterone releasing levels by testicles. 107 On the other hand, both Enzalutamide and Bicalutamide reduce the efficiency of the AR migration towards the nucleus, which results in the impairment of the AR-mediated signaling pathway. 106 Currently, the potential of Proxalutamide to manage prostate cancer has been studied. This molecule antagonizes the receptor of androgens and reduces the transcriptional levels of the same receptors and, therefore, their expression. 108 According to what we stated previously, and supported by other works, androgens promote the transcription of TMPRSS2, 109 which favours SARS-CoV-2 infection. 110 So, inhibiting the pathways related to androgens will decrease TMPRSS2 expression, which can mitigate the viral entrance F I G U R E 3 Active studies of drugs that interfere with cell signaling triggered by sex hormones. Adapted from 105 MATEUS ET AL.

-9 of 15 on cells and, so, its replication. 111, 112 Moreover, Proxalutamide is also able to lower the expression of ACE2, which can act synergistically with the activity of lowering the expression of TMPRSS2. 113 Spironolactone is a mineralocorticoid/aldosterone antagonist 114 that is commonly used in cases of resistant hypertension. 115 However, due to its antiandrogenic activity, it could be used by transgender females, as well. As a matter of fact, spironolactone seems to reduce the synthesis of testosterone, antagonizes ARs, and agonizes ER. 116 Taking into account both, the anti-hypertensive (because of the inhibition of the rennin-angiotensin-aldosterone system) and the anti-androgen effects of spironolactone (impacting on the TMPRSS2 expression), it was proposed that spironolactone would be a helpful tool on managing Covid-19 positive patients. 117 In order to convey as many targets as possible to stop Covid-19, it is possible to use combinations of molecules and some are currently being studied. The first combination that we will spell out is the association of isotretinoin with tamoxifen. Isotretinoin is a drug that is currently used to treat acne because of its antiandrogenic effect. 118 Indeed, isotretinoin diminishes the serum levels of dihydrotestosterone, 119, 120 which is an androgen that promotes the transcription of TMPRSS2. 109, 121 The effect of androgens on regulating the expression of TMPRSS2 was previously reported on lungs. 122 For this reason, it is tempting to speculate that suppressing the activity of androgens (including testosterone and dihydrotestosterone) will lead to the reduction of the expression of TMPRSS2, which results in less viral infection, 111 and this suppression may be induced by isotretinoin.

Beyond its antiandrogenic activity, Sinha et al. have found out recently that isotretinoin is a strong downregulator of ACE2 receptors, being the strongest one out of over 20000 molecules tested in vitro. 123 Taken together, isotretinoin may have a protective role due to suppression of TMPRSS2 and ACE2 expression.

Tamoxifen exerts effects beyond the ones related to estrogens.

Reportedly, tamoxifen inhibits the acidification of lysosomes and endosomes and decreases the rate of vesicular transport. Therefore, there are a lot of implications for many cellular functions. 124 Concretely, lysosomes and endosomes contain cathepsins. Cathepsins (Cat) are acidic proteases that display many functions on cells according to their location in the cell. Apparently, CatL is involved in the entrance process of SARS-CoV-2: firstly, SARS-CoV-2 binds to the ACE2 receptor and it is endocytosed. Here, TMPRSS2 and CatL perform an initial S protein proteolysis on the cell surface. Secondly, in the endosomes, CatL cleaves the S1 subunits, and the bound between SARS-CoV-2 and ACE2 is disrupted. Lastly, the viral membrane fuses with the endosome membrane, and the viral ssRNA is released into the cytosol. 125 Plus, cathepsin L may act synergistically with TMPRSS2, 126 but also as the mean of S protein priming when TMPRSS2 is absent from the cells' surface. 110 The next drug conjugation that is being assessed is the concomitant use of tamoxifen and all trans-retinoic acid. Also known as retinoic acid, all trans-retinoic acid displays many important functions, 127 for instance, the inhibition of the responses induced by the bradykinin B 1 receptor, displaying the immunomodulatory and anti-inflammatory effects of retinoic acid on Covid-19. 128 The rationale behind targeting those receptors was originated by the hypothesis that bradykinin B 1 receptor on endothelial cells of the lungs is upregulated in Covid-19 patients. This may be explained by the decrease of ACE2 receptors resultant of SARS-CoV-2 entrance in cells. 129 Accordingly, after the SARS-CoV-2 entrance into the cells via ACE2, this receptor won't be available to inactivate the potent ligand of the B 1 receptor des-Arg 9 bradykinin. As this ligand is not inactivated, the B1 receptor will remain in its active form, which results in vascular leakage and angioedema. 130 So, inhibiting bradykinin B 1 receptors may be an option to reverse the Covid-19-induced angioedema in the lungs. 131 Besides, all transretinoic acid displays an inhibitory effect on IL-6-driven induction of proinflammatory T H 17 and a promontory effect on the antiinflammatory T reg cell differentiation. 132 The last drug conjugation that we will explore has a similar purpose to the previous one. Indeed, the conjugation of spironolactone and bromhexine may be very beneficial. Despite its use as a mucolytic agent, 133 bromhexine showed to inhibit the TMPRSS2 in situations of infection by influenza A, MERS-CoV, 134 and, more recently, SARS-CoV-2. 135 Besides, bromhexine, after its metabolism, is converted into ambroxol, which is also active.

Interestingly, ambroxol displayed anti-SARS-CoV-2 activity by blocking ACE2. 136 As all these putative therapeutically options have the lungs as main target and, as previously stated, DCs are highly present in this organ. Therefore, it seems reasonable to hypothesise that all those molecules can also impact DCs function. The resulting effect on DCs can condition the immunological response by, for instance, interfering with antigen recognition, or even, with antigen presentation to T cells. 25 The evidence that pregnancy did not add risk to deterioration associated with Covid-19 and the higher mortality observed in postmenopausal women Covid-19 positive corroborate the hypothesis that estrogens can trigger a protective effect in Covid-19.

However, it is important to fully understand the complex interaction of sex hormones in different environments, knowing that the effects of E2 as a pro-or anti-inflammatory stimulus must be adjusted to the viral infection phase.

Lastly, there are active clinical trials aiming to find out therapeutic strategies disrupting the signaling pathways triggered by sex hormones and able to control the severity of Covid-19. The results of these studies are eagerly awaited, and our hope is that such efforts will soon be successful and drive the development of safe and effective treatments for Covid-19.

This research work has been carried out in the framework of project "TECNICOV -Desenvolvimento de testes rápidos para a monitorização de anticorpos em soro e saliva," co-financed by the European Regional Development Fund (POCI-01-02B7-FEDER-069745) through the Operational Programme for Competitiveness Factors (COMPETE) and by national funds through the National Innovation Agency.

World Health Organization. World Health Organization Declares COVID-19 a "Pandemic

International Center for Research on Women The Sex, Gender and COVID-19 Project | Global

The immune system is a natural target for estrogen action: opposing effects of estrogen in two prototypical autoimmune diseases

Clinical manifestation and laboratory characteristics of SARS-CoV-2 infection in pregnant women

17β-estradiol reduces SARS-CoV-2 infection in vitro

Estrogen receptors: how do they signal and what are their targets

Estrogen antiinflammatory activity on human monocytes is mediated through cross-talk between estrogen receptor ER a 36 and GPR30/GPER1

Estradiol promotes functional responses in inflammatory and steady-state dendritic cells through differential requirement for activation function-1 of estrogen receptor α

Optimizing dendritic cellbased immunotherapy: tackling the complexity of different arms of the immune system

Covid-19: time for a paradigm change

A novel coronavirus outbreak of global health concern

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Virus maturation by budding

Virus Host Interactions in SARS Coronavirus Infection

Prediction and prevention of the next pandemic zoonosis

Abdul Raub SH. Classical and alternative receptors for SARS-CoV-2 therapeutic strategy

Dendritic cells and SARS-CoV-2 infection: still an unclarified connection

The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade

Replication and expression strategies of viruses

Mast cells contribute to coronavirus-induced inflammation: new antiinflammatory strategy

Research progress on main symptoms of novel coronavirus pneumonia improved by traditional Chinese medicine

Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports

Cancer immunotherapy via dendritic cells

The role of lung dendritic cell subsets in immunity to respiratory viruses

Comparative review of SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza A respiratory viruses

Influenza and SARScoronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts

DC-SIGN and DC-SIGNR interact with the glycoprotein of marburg virus and the S protein of severe acute respiratory syndrome coronavirus

Association of a single nucleotide polymorphism in the CD209 (DC-SIGN) promoter with SARS severity

Orchestrated efforts on host network hijacking: processes governing virus replication

Autophagy-dependent viral recognition by plasmacytoid dendritic cells

Pathogen recognition by innate immunity and its signaling

Viral innate immune evasion and the pathogenesis of emerging RNA virus infections

Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon

Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection

MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells

Decisions about dendritic cells: past, present, and future

Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response

Pathology and pathogenesis of severe acute respiratory syndrome

Detection of severe acute respiratory syndrome coronavirus RNA in plasma during the course of infection

Chemokine up-regulation in SARS-coronavirus -infected, monocyte-derived human dendritic cells

Active replication of middle east respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis

Attenuated interferon and proinflammatory response in SARS-CoV-2-infected human dendritic cells is associated with viral antagonism of STAT1 phosphorylation

Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19

CD14 + CD16 ++ cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics

Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses

Phase I-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults

Estrogen receptor alpha and beta in health and disease

Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology

Development of subtypeselective oestrogen receptor-based therapeutics

The human estrogen receptor has two independent nonacidic transcriptional activation functions

What's new in estrogen receptor action in the female reproductive tract

Palmitoylation-dependent estrogen receptor alfa membrane localization: regulation by 17 beta estradiol

Estrogen receptors and human disease

Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes

Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alfa and beta

Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane

X-chromosome complement and estrogen receptor signaling independently contribute to the enhanced TLR7-mediated IFN-α production of plasmacytoid dendritic cells from women

Regulation of dendritic cell differentiation and function by estrogen receptor ligands

Estrogen receptor signaling promotes dendritic cell differentiation by increasing expression of the transcription factor IRF4

What on "Irf" Is this gene 4? Irf4 transcriptionfactor-dependent dendritic cells are required for T helper 2 cell responses in murine skin

Estrogen preferentially promotes the differentiation of CD11c + CD11b intermediate dendritic cells from bone marrow precursors

Expansion of CD4 + CD25 + and FOXP3 + regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction

Estradiol acts directly on bone marrow myeloid progenitors to differentially regulate GM-CSF or Flt3 ligand-mediated dendritic cell differentiation

The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor α signaling

Interleukin-12 and the regulation of innate resistance and adaptive immunity

Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases

Sex differences in plasmacytoid dendritic cell levels of IRF5 drive higher IFN-production in women

What's sex got to do with COVID-19? Gender-based differences in the host immune response to coronaviruses

17β-estradiol regulates cytokine release through modulation of CD16 expression in monocytes and monocyte-derived macrophages

Activation of the annexin A1 pathway underlies the protective effects exerted by estrogen in polymorphonuclear leukocytes

Sex-specific alterations in neutrophil apoptosis: the role of estradiol and progesterone

Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells

Tripartite combination of potential pandemic mitigation agents: vitamin D, Quercetin, and Estradiol manifest properties of candidate medicinal agents for mitigation of the severity of pandemic COVID-19 defined by genomics-guided tracing of SARS-CoV-2 targ

Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication

TLR7 ligands induce higher IFN-α production in females

Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites

Sex differences in immune responses

Estradiol, progesterone, immunomodulation, and COVID-19 outcomes

Androgen receptor structure, function and Biology : from bench to bedside

Do androgens modulate the pathophysiological pathways of inflammation? Appraising the contemporary evidence

Sex differences in immune responses: hormonal effects, antagonistic selection, and evolutionary consequences

Consistent production of a higher T(H)1:T(H)2 cytokine ratio by stimulated T cells in men compared with women

Testosterone decreases house dust mite-induced type 2 and IL-17A mediated airway inflammation

Tissue physiology and pathology of aromatase

ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy

The X chromosome in population genetics

X-inactivation profile reveals extensive variability in X-linked gene expression in females

COVID-19 and individual genetic susceptibility/Receptivity: role of ACE1/ACE2 genes, immunity, inflammation and coagulation. Might the double X-chromosome in females Be protective against SARS-CoV-2 compared to the single X-chromosome in Males ?

Inherent Xlinked genetic variability and cellular mosaicism unique to females contribute to sex-related differences in the innate immune response

The stress of finding NEMO

Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study

Variant IL-1 receptor-associated kinase-1 mediates increased NF-κB activity

Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor

Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein

Preliminary analysis of the association between methylation of the ACE2 promoter and essential hypertension

TLR7 escapes X chromosome inactivation in immune cells

Perspectives and challenges in the fight against COVID-19 : the role of genetic variability

Inflammatory and anti-inflammatory markers in plasma: from late pregnancy to early postpartum

The role of the anti-inflammatory cytokine interleukin-10 in tissue fibrosis

Primary effect of 1α,25(OH)2D3 on IL-10 expression in monocytes is short-term down-regulation

Proteinase-activated receptors in fibroproliferative lung disease

The pattern of expression of protease-activated receptors (PARs) during early trophoblast development

Sex hormones and hormone therapy during Covid-19 pandemic: implications for patients with cancer

GnRH antagonists have direct inhibitory effects on castration-resistant prostate cancer via intracrine androgen and AR-V7 expression

Anti-androgen hormonal therapy for cancer and other diseases

Degarelix versus luteinizing hormone-releasing hormone agonists for the treatment of prostate cancer

Preclinical profile and phase I clinical trial of a novel androgen receptor antagonist GT0918 in castration-resistant prostate cancer

Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor

Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)

Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide

Proxalutamide significantly accelerates viral clearance and reduces time to clinical remission in patients with mild to moderate COVID-19: results from a randomized, double-blinded, placebo-controlled trial

Heart failure and chronic kidney disease: should we use spironolactone?

ESH Guidelines for the management of arterial hypertension

The utility of potassium monitoring in gender-diverse adolescents taking spironolactone

Spironolactone may provide protection from SARS-CoV-2: targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS)

The use of isotretinoin for acne-an update on optimal dosing, surveillance, and adverse effects

Effect of isotretinoin on serum levels of precursor and peripherally derived androgens in patients with acne

The effect of low-dose isotretinoin therapy on serum androgen levels in women with acne vulgaris

Covid-19 pathogenesis in prostatic cancer and TMPRSS2-ERG regulatory genetic pathway

Androgen receptor and androgen-dependent gene expression in lung

In vitro and in vivo identification of clinically approved drugs that modify ACE 2 expression

Tamoxifen inhibits acidification in cells independent of the estrogen receptor

Pharmacology & Therapeutics Cathepsin L-selective inhibitors : a potentially promising treatment for COVID-19 patients

Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARSCoV-2 infection

Overview of retinoid metabolism and function

Retinoids inhibit bradykinin B1 receptor-sensitized responses in human umbilical vein

COVID-19-Associated Cardiovascular Complications Published online

Attenuation of pulmonary ACE2 activity impairs inactivation of des-arg9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration

Kallikrein-kinin blockade in patients with Covid-19 to prevent acute respiratory distress syndrome

Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid

A reappraisal of the mucoactive activity and clinical efficacy of bromhexine

Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection

Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: a randomized clinical trial

Ambroxol Hydrochloride Inhibits the Interaction between Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein's Receptor Binding Domain and Recombinant Human ACE2. bioRxiv

Estrogen Patch for COVID-19 Symptoms

Estrogen Therapy in Nonsevere COVID-19 Patients

Oestrogen Treatment for COVID-19 Symptoms

Estetrol (E4) for the Treatment of Patients With Confirmed SARS-COV-2 Infection

Progesterone for the Treatment of COVID-19 in Hospitalized Men

Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization

Covidenza -a prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial

Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection

Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit

Anti-Androgen Treatment for COVID-19

Proxalutamide Treatment for COVID-19 Female Outpatients

Camostat With Bicalutamide for COVID-19

Spironolactone in Covid-19 Induced ARDS. 2020

Estradiol and Progesterone in Hospitalized COVID-19 Patients

Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against Severe Acute Respiratory Syndrome Coronavirus

Combination of Chemopreventive Agents (All-Trans Retinoic Acid and Tamoxifen) as Potential Treatment for the Lung Complication of COVID-19

BromhexIne And Spironolactone For Coronа-VirUs Infection Requiring HospiTalization (BISCUIT)

No conflict of interest declared. Tecnimed Group Company had no role in the design of the study; in the writing of the manuscript, or in the decision to publish the study. All authors read and approved the final manuscript.

Data sharing is not applicable to this article as no new data were created or analysed in this study.

https://orcid.org/0000-0002-7511-4358